{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:59:18Z","timestamp":1776873558148,"version":"3.51.2"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>This retrospective study highlights the salient aspects of a series of feline patients affected with bisphosphonate related osteonecrosis of the jaw. Though more commonly published in human literature, this presentation is rare in cats. The authors hope that this study will assist in making this a more globally known entity with subsequent improved prognosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data was retrospectively obtained from the medical records between 2015 and 2021 of 20 cats with Medication Related Osteonecrosis of the Jaw. Data included patient information, clinical history, presenting complaint, systemic diseases, details referable to hypercalcemia and treatment thereof, bisphosphonate specifics (dose and duration), clinical presentation of the lesion, diagnostic testing including radiographic and histopathologic descriptions, treatment, and outcome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Pertinent results include that all 20 cats who developed Medication Related Osteonecrosis of the Jaw had been treated for idiopathic hypercalcemia with the bisphosphonate medication alendronate. Eighty-five percent of the cases had prior dental extractions at the site of MRONJ lesion. Ninety-five percent of the affected cats required a surgical procedure to control the disease. Thirty-five percent of cases required at least one revision surgery after the initial procedure was performed. Diagnosis of MRONJ was made by a correlation of diagnostic findings and patient history. No single diagnostic, or combination was pathognomonic for lesion diagnosis. As well, there were no statistically significant associations between patient variables assessed and the overall patient outcome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>The case series reveals that cats with feline idiopathic hypercalcemia treated with alendronate may be at a risk for development of MRONJ, a serious oral condition with significant morbidity. Prior dental extraction sites in patients concurrently treated with bisphosphonate medications were often associated with MRONJ lesions. Therefore, any needed dental surgery should be performed prior to the use of bisphosphonates where possible. The authors have also included a relevant comparative literature review.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fvets.2024.1436988","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T04:48:12Z","timestamp":1724388492000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["A retrospective case series on bisphosphonate related osteonecrosis of the jaw in 20 cats"],"prefix":"10.3389","volume":"11","author":[{"given":"Suzanna L.","family":"Hatunen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie G.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia M.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo C.","family":"Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew D.","family":"Finkelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie H.","family":"Shope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the jaws\u20142022 update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J Oral Maxillofac Surg"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.14219\/jada.archive.2011.0108","article-title":"Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis","volume":"142","author":"Hellstein","year":"2011","journal-title":"J Am Dent Assoc"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1177\/089875641102800413","article-title":"Bisphosphonate related osteonecrosis of the jaws: A review","volume":"28","author":"Stepaniuk","year":"2011","journal-title":"J Vet Dent"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00774-016-0810-7","article-title":"Antiresorptive agent-related osteonecrosis of the jaw: position paper 2017 of the Japanese allied committee on osteonecrosis of the jaw","volume":"35","author":"Yoneda","year":"2017","journal-title":"J Bone Min Metab"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: A systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J Bone Miner Res"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.ijom.2015.01.026","article-title":"Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review","volume":"44","author":"Fliefel","year":"2015","journal-title":"Int J Oral Maxillofac Surg"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.job.2019.03.005","article-title":"Medication-related osteonecrosis of the jaw: A literature review","volume":"61","author":"Kuroshima","year":"2019","journal-title":"J Oral Biosci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/jvim.15409","article-title":"Medication-related osteonecrosis of the jaw after long-term bisphosphonate treatment in a cat","volume":"33","author":"Larson","year":"2019","journal-title":"J Vet Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/jvim.13980","article-title":"Zoledronate-associated osteonecrosis of the jaw in a dog with appendicular osteosarcoma","volume":"30","author":"Lundberg","year":"2016","journal-title":"J Vet Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.joms.2008.01.038","article-title":"Mandible matrix necrosis in beagle dogs after 3 years of daily Oral bisphosphonate treatment","volume":"66","author":"Allen","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1601-6343.2009.01456.x","article-title":"Mandibular necrosis in beagle dogs treated with bisphosphonates","volume":"12","author":"Burr","year":"2009","journal-title":"Orthod Craniofac Res"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"280","DOI":"10.2353\/ajpath.2010.090592","article-title":"Bisphosphonates cause osteonecrosis of the jaw-like disease in mice","volume":"177","author":"Bi","year":"2010","journal-title":"Am J Pathol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/iep.12007","article-title":"Experimental development of bisphosphonate-related osteonecrosis of the jaws in rodents","volume":"94","author":"Conte Neto","year":"2013","journal-title":"Int J Exp Pathol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jcms.2018.08.011","article-title":"Influence of induced infection in medication-related osteonecrosis of the jaw development after tooth extraction: A study in rats","volume":"47","author":"Bolette","year":"2019","journal-title":"J Craniofac Surg"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/j.1600-0714.2011.01125.x","article-title":"Bisphosphonate-induced osteonecrosis of the jaw in a rat model arises first after the bone has become exposed. No primary necrosis in unexposed bone","volume":"41","author":"Abtahi","year":"2012","journal-title":"J Oral Pathol Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00784-015-1468-6","article-title":"Zoledronate induces bisphosphonate-related osteonecrosis of the jaw in osteopenic sheep","volume":"20","author":"Voss","year":"2016","journal-title":"Clin Oral Investig"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.bone.2012.04.020","article-title":"Bisphosphonate related osteonecrosis of the jaw: A minipig large animal model","volume":"51","author":"Pautke","year":"2012","journal-title":"Bone"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.3390\/medicina59051000","article-title":"Chronic periodontal infection and not iatrogenic interference is the trigger of medication-related osteonecrosis of the jaw: Insights from a large animal study (PerioBRONJ pig model)","volume":"59","author":"Troeltzsch","year":"2023","journal-title":"Medicina (Lithuania)"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11657-020-00761-0","article-title":"Therapeutic approach and management algorithms in medication-related osteonecrosis of the jaw (MONJ): recommendations of a multidisciplinary group of experts","volume":"15","author":"Chalem","year":"2020","journal-title":"Arch Osteoporos"},{"key":"ref20","first-page":"354","article-title":"Summary of ASBMR Task Force on ONJ","volume":"7","author":"Burr","year":"2007","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1210\/jc.2006-2036","article-title":"Possible association between diabetes and bisphosphonate-related jaw osteonecrosis","volume":"92","author":"Khamaisi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.oooo.2018.08.021","article-title":"The American Academy of Oral medicine clinical practice statement: dental care for the patient on antiresorptive drug therapy","volume":"127","author":"Bugueno","year":"2019","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cvsm.2016.09.004","article-title":"Update on feline ionized hypercalcemia","volume":"47","author":"De Brito Galv\u00e3o","year":"2017","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/jvim.12507","article-title":"Treatment of ionized hypercalcemia in 12 cats (2006-2008) using PO-administered alendronate","volume":"29","author":"Hardy","year":"2015","journal-title":"J Vet Intern Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/jvim.16627","article-title":"Ionized hypercalcemia in 238 cats from a referral hospital population (2009-2019)","volume":"37","author":"Broughton","year":"2023","journal-title":"J Vet Intern Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jfms.2010.09.011","article-title":"Use of bisphosphonates to treat severe idiopathic hypercalcaemia in a young ragdoll cat","volume":"13","author":"Whitney","year":"2011","journal-title":"J Feline Med Surg"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1111\/jvim.16508","article-title":"Alendronate treatment in cats with persistent ionized hypercalcemia: A retrospective cohort study of 20 cases","volume":"36","author":"Kurtz","year":"2022","journal-title":"J Vet Intern Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1177\/20551169231183752","article-title":"Management of insufficiency fractures associated with long-term bisphosphonate therapy in a cat","volume":"9","author":"Meneghetti","year":"2023","journal-title":"J Feline Med Surg Open Rep"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1177\/089875640902600201","article-title":"Alendronate binds to tooth root surfaces and inhibits progression of feline tooth resorption: A pilot proof-of-concept study","volume":"26","author":"Mohn","year":"2009","journal-title":"J Vet Dent"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.5326\/JAAHA-MS-6933","article-title":"2019 AAHA dental care guidelines for dogs and cats*","volume":"55","author":"Bellows","year":"2019","journal-title":"J Am Anim Hosp Assoc"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jocd.2016.09.005","article-title":"Case-based review of osteonecrosis of the jaw (ONJ) and application of the international recommendations for management from the international Task Force on ONJ","volume":"20","author":"Khan","year":"2017","journal-title":"J Clin Densitom"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00198-010-1268-4","article-title":"Compromised osseous healing of dental extraction sites in zoledronic acid-treated dogs","volume":"22","author":"Allen","year":"2011","journal-title":"Osteoporos Int"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"104007","DOI":"10.1016\/j.jevs.2022.104007","article-title":"Retrospective analysis of the use of tiludronate in equine practice: safety on 1804 horses, efficacy on 343 horses","volume":"115","author":"Tischmacher","year":"2022","journal-title":"J Equine Vet"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.3390\/ani12131722","article-title":"Is the use of bisphosphonates putting horses at risk? An osteoclast perspective","volume":"12","author":"Vergara-Hernandez","year":"2022","journal-title":"Animals"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2045-824X-5-1","article-title":"Bisphosphonate-related osteonecrosis of jaw (BRONJ): Diagnostic criteria and possible pathogenic mechanisms of an unexpected anti-angiogenic side effect","volume":"5","author":"Sharma","year":"2013","journal-title":"Vascular Cell"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1056\/NEJMoa1916525","article-title":"Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates","volume":"383","author":"Black","year":"2020","journal-title":"N Engl J Med"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.bone.2017.06.018","article-title":"Fracture during oral bisphosphonate therapy is associated with deteriorated bone material strength index","volume":"103","author":"Nogu\u00e9s","year":"2017","journal-title":"Bone"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"72713","DOI":"10.1177\/2055116917727137","article-title":"Bilateral patellar fractures and increased cortical bone thickness associated with long-term oral alendronate treatment in a cat","volume":"3","author":"Dyce","year":"2017","journal-title":"J Feline Med Surg Open Rep"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1177\/08987564231175594","article-title":"Characterization of Oral pathology in cats affected by patellar fracture and dental anomaly syndrome (PADS)","volume":"40","author":"Bell","year":"2023","journal-title":"J Vet Dent"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.ijom.2013.02.007","article-title":"Prevention of osteonecrosis of the jaw by mucoperiosteal coverage in a rat model","volume":"42","author":"Abtahi","year":"2013","journal-title":"Int J Oral Maxillofac Surg"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/odi.12708","article-title":"Risk factors for medication-related osteonecrosis of the jaws: A systematic review","volume":"24","author":"McGowan","year":"2018","journal-title":"Oral Dis"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s40729-021-00323-0","article-title":"Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review","volume":"7","author":"Kawahara","year":"2021","journal-title":"Int J Implant Dent"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1093\/annonc\/mdm370","article-title":"A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients","volume":"18","author":"Jadu","year":"2007","journal-title":"Ann Oncol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/j.amjmed.2008.12.005","article-title":"Osteonecrosis of the jaw and the role of bisphosphonates: A critical review","volume":"122","author":"Silverman","year":"2009","journal-title":"Am J Med"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1177\/0300985815591079","article-title":"Histologic, clinical, and radiologic findings of alveolar bone expansion and osteomyelitis of the jaws in cats","volume":"52","author":"Bell","year":"2015","journal-title":"Vet Pathol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cvsm.2021.08.003","article-title":"Diagnostic imaging of Oral and maxillofacial anatomy and pathology","volume":"52","author":"Villamizar-Martinez","year":"2022","journal-title":"Vet Clin N Am Small Anim pract"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1016\/j.joms.2010.07.017","article-title":"Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism","volume":"68","author":"Otto","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1053\/j.tcam.2008.02.003","article-title":"Periodontal disease","volume":"23","author":"Niemiec","year":"2008","journal-title":"Top Companion Anim Med"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijerph17165998","article-title":"Medication-related osteonecrosis of jaws (MRONJ) prevention and diagnosis: Italian consensus update 2020","volume":"17","author":"Campisi","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"ref51","first-page":"926","article-title":"Physiological disposition of alendronate, a potent anti-osteolytic bisphosphonate, in laboratory animals","volume":"19","author":"Lin","year":"1991","journal-title":"Drug Metab Dispos"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","article-title":"Denosumab and bisphosphonates: Different mechanisms of action and effects","volume":"48","author":"Baron","year":"2011","journal-title":"Bone"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.oraloncology.2014.08.016","article-title":"A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ)","volume":"50","author":"Rupel","year":"2014","journal-title":"Oral Oncol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.joms.2012.04.001","article-title":"What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: A randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics","volume":"70","author":"Freiberger","year":"2012","journal-title":"J Oral Maxillofac Surg"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1600-0714.2011.01091.x","article-title":"Bisphosphonates-related osteonecrosis of the jaws: A concise review of the literature and a report of a single-Centre experience with 151 patients","volume":"41","author":"Vescovi","year":"2012","journal-title":"J Oral Pathol Med"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.oraloncology.2011.12.004","article-title":"Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: A report of 32 cases","volume":"48","author":"Mozzati","year":"2012","journal-title":"Oral Oncol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.oraloncology.2011.01.002","article-title":"Efficacy and safety of medical ozone (O3) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: preliminary results of a phase I-II study","volume":"47","author":"Ripamonti","year":"2011","journal-title":"Oral Oncol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1746-160X-7-16","article-title":"Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw","volume":"7","author":"Cella","year":"2011","journal-title":"Head Face Med"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.tripleo.2010.05.067","article-title":"Management of bisphosphonate-associated osteonecrosis: Pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series","volume":"110","author":"Epstein","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.joms.2010.07.014","article-title":"Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study","volume":"69","author":"Pautke","year":"2011","journal-title":"J Oral Maxillofac Surg"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1056\/NEJMoa1005361","article-title":"Teriparatide and osseous regeneration in the Oral cavity","volume":"363","author":"Bashutski","year":"2010","journal-title":"N Engl J Med"},{"key":"ref62","first-page":"66","volume-title":"Oral and maxillofacial surgery in dogs and cats","author":"Verstraete","year":"2019"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"115711","DOI":"10.1016\/j.bone.2020.115711","article-title":"Bisphosphonates in veterinary medicine: The new horizon for use","volume":"142","author":"Suva","year":"2021","journal-title":"Bone"}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2024.1436988\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T04:48:20Z","timestamp":1724388500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2024.1436988\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,23]]},"references-count":63,"alternative-id":["10.3389\/fvets.2024.1436988"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2024.1436988","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,23]]},"article-number":"1436988"}}